Literature DB >> 22522110

Salt-inducible kinase 1 regulates E-cadherin expression and intercellular junction stability.

Kristina Eneling1, Laura Brion, Vanda Pinto, Maria J Pinho, Jacob I Sznajder, Naoki Mochizuki, Kazuo Emoto, Patricio Soares-da-Silva, Alejandro M Bertorello.   

Abstract

The protein kinase liver kinase B1 (LKB1) regulates cell polarity and intercellular junction stability. Also, LKB1 controls the activity of salt-inducible kinase 1 (SIK1). The role and relevance of SIK1 and its downstream effectors in linking the LKB1 signals within these processes are partially understood. We hypothesize that SIK1 may link LKB1 signals to the maintenance of epithelial junction stability by regulating E-cadherin expression. Results from our studies using a mouse lung alveolar epithelial (MLE-12) cell line or human renal proximal tubule (HK2) cell line transiently or stably lacking the expression of SIK1 (using SIK1 siRNAs or shRNAs), or with its expression abrogated (sik1(+/+) vs. sik1(-/-) mice), indicate that suppression of SIK1 (∼40%) increases the expression of the transcriptional repressors Snail2 (∼12-fold), Zeb1 (∼100%), Zeb2 (∼50%), and TWIST (∼20-fold) by activating cAMP-response element binding protein. The lack of SIK1 and activation of transcriptional repressors decreases the availability of E-cadherin (mRNA and protein expression by ∼100 and 80%, respectively) and the stability of intercellular junctions in epithelia (decreases in transepithelial resistance). Furthermore, LKB1-mediated increases in E-cadherin expression are impaired in cells where SIK1 has been disabled. We conclude that SIK1 is a key regulator of E-cadherin expression, and thereby contributes to the stability of intercellular junctions.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22522110      PMCID: PMC3405263          DOI: 10.1096/fj.12-205609

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  39 in total

1.  Na,K-ATPase beta-subunit is required for epithelial polarization, suppression of invasion, and cell motility.

Authors:  S A Rajasekaran; L G Palmer; K Quan; J F Harper; W J Ball; N H Bander; A Peralta Soler; A K Rajasekaran
Journal:  Mol Biol Cell       Date:  2001-02       Impact factor: 4.138

2.  The transcription factor snail is a repressor of E-cadherin gene expression in epithelial tumour cells.

Authors:  E Batlle; E Sancho; C Francí; D Domínguez; M Monfar; J Baulida; A García De Herreros
Journal:  Nat Cell Biol       Date:  2000-02       Impact factor: 28.824

3.  The transcription factor Slug represses E-cadherin expression and induces epithelial to mesenchymal transitions: a comparison with Snail and E47 repressors.

Authors:  Victoria Bolós; Hector Peinado; Mirna A Pérez-Moreno; Mario F Fraga; Manel Esteller; Amparo Cano
Journal:  J Cell Sci       Date:  2003-02-01       Impact factor: 5.285

4.  Complete polarization of single intestinal epithelial cells upon activation of LKB1 by STRAD.

Authors:  Annette F Baas; Jeroen Kuipers; Nicole N van der Wel; Eduard Batlle; Henk K Koerten; Peter J Peters; Hans C Clevers
Journal:  Cell       Date:  2004-02-06       Impact factor: 41.582

5.  Altered LKB1/CREB-regulated transcription co-activator (CRTC) signaling axis promotes esophageal cancer cell migration and invasion.

Authors:  Y Gu; S Lin; J-L Li; H Nakagawa; Z Chen; B Jin; L Tian; D A Ucar; H Shen; J Lu; S N Hochwald; F J Kaye; L Wu
Journal:  Oncogene       Date:  2011-06-27       Impact factor: 9.867

6.  Salt-inducible kinase is involved in the ACTH/cAMP-dependent protein kinase signaling in Y1 mouse adrenocortical tumor cells.

Authors:  X Lin ; H Takemori; Y Katoh; J Doi; N Horike; A Makino; Y Nonaka; M Okamoto
Journal:  Mol Endocrinol       Date:  2001-08

7.  Extinction of E-cadherin expression in breast cancer via a dominant repression pathway acting on proximal promoter elements.

Authors:  K M Hajra; X Ji; E R Fearon
Journal:  Oncogene       Date:  1999-12-02       Impact factor: 9.867

8.  LKB1 is a master kinase that activates 13 kinases of the AMPK subfamily, including MARK/PAR-1.

Authors:  Jose M Lizcano; Olga Göransson; Rachel Toth; Maria Deak; Nick A Morrice; Jérôme Boudeau; Simon A Hawley; Lina Udd; Tomi P Mäkelä; D Grahame Hardie; Dario R Alessi
Journal:  EMBO J       Date:  2004-02-19       Impact factor: 11.598

9.  The p120 catenin family: complex roles in adhesion, signaling and cancer.

Authors:  P Z Anastasiadis; A B Reynolds
Journal:  J Cell Sci       Date:  2000-04       Impact factor: 5.285

10.  A novel role for p120 catenin in E-cadherin function.

Authors:  Renee C Ireton; Michael A Davis; Jolanda van Hengel; Deborah J Mariner; Kirk Barnes; Molly A Thoreson; Panos Z Anastasiadis; Linsey Matrisian; Linda M Bundy; Linda Sealy; Barbara Gilbert; Frans van Roy; Albert B Reynolds
Journal:  J Cell Biol       Date:  2002-11-11       Impact factor: 10.539

View more
  13 in total

1.  Pathological implications of cadherin zonation in mouse liver.

Authors:  Madlen Hempel; Annika Schmitz; Sandra Winkler; Ozlem Kucukoglu; Sandra Brückner; Carien Niessen; Bruno Christ
Journal:  Cell Mol Life Sci       Date:  2015-02-17       Impact factor: 9.261

2.  Salt-inducible kinase 3 deficiency exacerbates lipopolysaccharide-induced endotoxin shock accompanied by increased levels of pro-inflammatory molecules in mice.

Authors:  Masato Sanosaka; Minoru Fujimoto; Tomoharu Ohkawara; Takahiro Nagatake; Yumi Itoh; Mai Kagawa; Ayako Kumagai; Hiroyuki Fuchino; Jun Kunisawa; Tetsuji Naka; Hiroshi Takemori
Journal:  Immunology       Date:  2015-06       Impact factor: 7.397

3.  Inositol pyrophosphates promote tumor growth and metastasis by antagonizing liver kinase B1.

Authors:  Feng Rao; Jing Xu; Chenglai Fu; Jiyoung Y Cha; Moataz M Gadalla; Risheng Xu; James C Barrow; Solomon H Snyder
Journal:  Proc Natl Acad Sci U S A       Date:  2015-01-23       Impact factor: 11.205

4.  Knob protein enhances epithelial barrier integrity and attenuates airway inflammation.

Authors:  Sung Gil Ha; Mythili Dileepan; Xiao Na Ge; Bit Na Kang; Yana G Greenberg; Amrita Rao; Girija Muralidhar; Lali Medina-Kauwe; Michael A Thompson; Christina M Pabelick; Scott M O'Grady; Savita P Rao; P Sriramarao
Journal:  J Allergy Clin Immunol       Date:  2018-03-06       Impact factor: 14.290

5.  Cadherin expression, vectorial active transport, and metallothionein isoform 3 mediated EMT/MET responses in cultured primary and immortalized human proximal tubule cells.

Authors:  Andrea Slusser; Chandra S Bathula; Donald A Sens; Seema Somji; Mary Ann Sens; Xu Dong Zhou; Scott H Garrett
Journal:  PLoS One       Date:  2015-03-24       Impact factor: 3.240

Review 6.  Corepressor metastasis-associated protein 3 modulates epithelial-to-mesenchymal transition and metastasis.

Authors:  Liang Du; Zhifeng Ning; Hao Zhang; Fuxing Liu
Journal:  Chin J Cancer       Date:  2017-03-09

7.  The protein kinase SIK downregulates the polarity protein Par3.

Authors:  Michael Vanlandewijck; Mahsa Shahidi Dadras; Marta Lomnytska; Tanzila Mahzabin; Martin Lee Miller; Christer Busch; Søren Brunak; Carl-Henrik Heldin; Aristidis Moustakas
Journal:  Oncotarget       Date:  2017-12-31

8.  ZEB1 insufficiency causes corneal endothelial cell state transition and altered cellular processing.

Authors:  Ricardo F Frausto; Doug D Chung; Payton M Boere; Vinay S Swamy; Huong N V Duong; Liyo Kao; Rustam Azimov; Wenlin Zhang; Liam Carrigan; Davey Wong; Marco Morselli; Marina Zakharevich; E Maryam Hanser; Austin C Kassels; Ira Kurtz; Matteo Pellegrini; Anthony J Aldave
Journal:  PLoS One       Date:  2019-06-13       Impact factor: 3.240

9.  Attenuated LKB1-SIK1 signaling promotes epithelial-mesenchymal transition and radioresistance of non-small cell lung cancer cells.

Authors:  Yuan-Hu Yao; Yan Cui; Xiang-Nan Qiu; Long-Zhen Zhang; Wei Zhang; Hao Li; Jin-Ming Yu
Journal:  Chin J Cancer       Date:  2016-06-07

Review 10.  The potent roles of salt-inducible kinases (SIKs) in metabolic homeostasis and tumorigenesis.

Authors:  Zicheng Sun; Qiwei Jiang; Jie Li; Jianping Guo
Journal:  Signal Transduct Target Ther       Date:  2020-08-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.